Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article,Cancer Biology & Therapy

当前位置： X-MOL 学术 › Cancer Biol. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article
Cancer Biology & Therapy ( IF 3.6 ) Pub Date : 2023-11-13 , DOI: 10.1080/15384047.2023.2274123
Qiantong Dong ₁ , Chenbin Chen _{1,

2} , Yuanbo Hu _{1,

2} , Weiteng Zhang ₁ , Xinxin Yang ₂ , Yingxue Qi ₃ , Chan Zhu ₃ , Xiaodong Chen ₁ , Xian Shen _{1,

2} , Weiping Ji _{1,

2}

Affiliation

Molecular residual disease (MRD), detected by circulating tumor DNA (ctDNA) can be involved in the entire process of solid tumor management, including recurrence prediction, efficacy evaluation, an...

中文翻译：